| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.0096 | 0.9 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.034 | 0.9 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.007 | 0.9 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |